Piuri, G., Basello, K., Rossi, G., Soldavini, C.M, Duiella, S., Privitera, G., et al. (2020) Methylglyoxal, Glycated Albumin, PAF, and TNF- Possible Inflammatory and Metabolic Biomarkers for Management of Gestational Diabetes. Nutrients, 12, Article 479.
https://doi.org/10.3390/nu12020479

has been cited by the following article:

• TITLE: The Use of Glycated Albumin in the Diagnosis of Gestational Diabetes Mellitus

  AUTHORS: Atochi Prince Woruka, Celestine Osita John

  KEYWORDS: Glycated Albumin, Gestational Diabetes Mellitus, Oral Glucose Tolerance Test, University of Port Harcourt Teaching Hospital

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.1, January 8, 2024

  ABSTRACT: Gestational diabetes mellitus is the most common endocrine disorder in pregnancy and a cause of maternal and fetal morbidities and mortalities. The oral glucose tolerance test is the gold standard for diagnosing gestational diabetes mellitus. Nevertheless, the oral glucose tolerance test is time-consuming and requires patient preparation. On the contrary, Glycated albumin does not require patient preparation or administration of any substance. Most studies on glycated albumin in pregnancy were among the non-African population, and black Americans have higher glycated albumin levels than Caucasians. This study determined the use of glycated albumin in diagnosing gestational diabetes mellitus among pregnant women. The study was a prospective study of 160 pregnant women between 24 and 28 weeks of gestation at the University of Port Harcourt Teaching Hospital. The diagnosis of gestational diabetes mellitus was based on the World Health Organization 2013 criteria. The diagnostic value of glycated albumin was determined using the area under the receiver operator characteristic curve. The prevalence of gestational diabetes mellitus was 9.4% and the mean glycated albumin was 16.91% (±2.77). The area under the receiver operator characteristic curve for glycated albumin was 0.845 (95% CI 0.733 - 0.956; p = 0.0001). The optimal cut-off value of glycated albumin in the diagnosis of gestational diabetes mellitus was 18.9%. Glycated albumin was useful in the diagnosis of gestational diabetes mellitus at 24 to 28 weeks of gestation.